Cardiopulmonary
A Patient Registry of the Real-world Use of Oral Treprostinil
For more information visit: ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH-Specific Background Therapy in Subjects With WHO Group 1 PAH
For more information visit: ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
For more information visit: ClinicalTrials.gov
A 16-Week, Multicenter, Open-label Study of Parenteral Treprostinil Induction Followed by Oral Treprostinil Optimization in Subjects With Pulmonary Arterial Hypertension
For more information visit: ClinicalTrials.gov
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
For more information visit: ClinicalTrials.gov
An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Treprostinil Inhalation Solution
For more information visit: ClinicalTrials.gov